For patients with celiac diseasean autoimmune condition triggered by glutenquestions naturally arise about medication safety and tolerability
Our firm has a long history of holding powerful corporations accountable when unsafe products cause real harm, and we are bringing that same approach to emerging pharmaceutical litigation
Ozempic and the Risk of nAMD A recent article in JAMA Ophthamology (June 2025) suggests that vascular changes triggered by GLP-1 activity may trigger or worsen nAMD in some patients, especially those who are older, diabetic, or already at risk for macular degeneration
Do I need dose adjustments if I have kidney problems
For the latest information, it is recommended to review the ingredient list printed on the packaging of the product prior to usage or consumption
- Compiled by RIA Staff Provided By RIA Published: Apr 21, 2026 The report you are trying to access is not visible because you're not logged in